reports being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics, being a paid consultant for Procter & Gamble and Zehna Therapeutics, having received research funds from Procter & Gamble, Zehna Therapeutics, and Roche Diagnostics, and being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland HeartLab and Procter & Gamble
Not relevant for the typical post-menopausal patient but worth stating explicitly
In addition to probiotics and prebiotics, other dietary interventions, including polyphenols, omega-3 fatty acids, and other anti-inflammatory nutrients, are also under investigation for their potential to regulate gut inflammation and protect the BBB (Winiarska-Mieczan et al., 2023)
Hubermans assertions in this podcast extends beyond the scope of this platform, its worth noting that the majority of his insights are based on solid reasoning and are commendable